FN2
FN2 is an autonomous stock decision engine. Instead of you running the same research loop every morning, FN2 dispatches AI agents that watch the markets, do the deep research on a schedule, and deliver the answer to your Inbox, Phone, or Discord.
Describe what you want to track in natural language: A ticker, a sector, a thesis, or a question like "alert me when NVDA's guidance changes" or pick a pre-built agent. FN2 turns it into an autonomous research agent that runs on your schedule: before the open, right after earnings, or weekly. Each agent reads earnings-call transcripts, pulls FRED macro data, screens tickers, builds charts, and reasons over all of it — then delivers a decision-ready brief, not a pile of raw data. No tabs, no screeners, no manual morning research. Built for serious individual investors and analysts who are drowning in tabs, transcripts, and screeners doing the same work by hand every day.
Learn more about FN2
BioSniper
BioSniper is a biotech research platform for equity analysts, investors, and life-science researchers. Users describe a research or investment thesis in plain English, and the platform compiles it into a structured workflow with screens, specialist-agent checks, scoring, blocking rules, and evidence gates. It searches seven public-source families: SEC EDGAR filings and insider transactions, FDA events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market data. Findings link to source records, and missing or conflicting evidence is marked unknown rather than guessed; source and as-of dates are shown where available. BioSniper also offers a free public biotech event calendar, an SEC cash runway calculator, and an open-source Python toolkit.
Learn more about BioSniper
EquiReason
EquiReason is an equity research and market-intelligence platform for self-directed investors, independent analysts and research teams. It combines SEC company filings, XBRL financial data, earnings-call transcripts and market information to help users examine financial performance, ownership activity, trends and company exposure. The platform traces market events through economic mechanisms to potentially affected companies and presents each company verdict with supporting and counter-evidence. Research views include financial statements, valuation context, insider and institutional activity, segment revenue data, company-specific measures and alerts, with evidence linked to its underlying source. EquiReason is available through the web and an iPhone app, with a free plan and paid research tiers. It provides research and decision support, not investment advice.
Learn more about EquiReason
AlphaYou
AlphaYou is a web-based US stock research platform for individual investors and researchers. It combines ticker-level research with trackers for disclosures by company insiders, institutional funds, members of Congress, public market commentators and selected traders, as well as federal contract awards linked to publicly traded companies. Users can review company fundamentals, earnings, financial history, technical indicators and news; inspect filing dates and source records; follow stocks or public sources; and set alerts for reported activity. The platform also publishes stock calls and explanatory commentary. Its research is informational rather than personalized investment advice, and it does not execute trades or manage customer assets. A free plan provides limited stock research, saved-stock and source-tracker capacity, and alerts. Paid plans increase access to tracker data and filing history, raise usage limits and add real-time alerts.
Learn more about AlphaYou